News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–16
Matches
16
Sources here
4
Companies here
1
Search results Stored financial headlines

Active search

16 matching headlines

Ticker or company: XBITMain company stories
Clear
Latest

MarketBeat Earnings

XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results, Misses Estimates By $0.25 EPS

XBiotech (NASDAQ:XBIT) reported a quarterly loss of $0.22 per share, significantly missing analysts' consensus estimate of a $0.03 profit by $0.25. Following the announcement, XBIT shares fell by $0.13 to $2.33, nearing its 52-week low, and the company's market capitalization is approximately $71 million. Wall Street sentiment remains negative, with Weiss Ratings downgrading the stock to "sell (e+)" …

Main company 🇺🇸 United States
Read at MarketBeat
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
KVUE Earnings Main company 🇺🇸 United States

XBiotech: Q2 Earnings Snapshot

This article is an earnings snapshot for XBiotech's Q2 performance. It is a placeholder without actual financial details, suggesting that the full earnings report would contain the relevant financial data.

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

XBiotech (NASDAQ: XBIT) trims R&D spend yet remains loss-making in Q2 2026

XBiotech Inc. reported a Q2 2026 net loss of $6.7 million and a six-month net loss of $12.2 million, despite significantly reducing research and development and general and administrative expenses. The clinical-stage biopharmaceutical company does not anticipate generating revenue in 2026 and expects continued …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TradingKey Earnings Main company 🇺🇸 United States

XBiotech Inc (XBIT) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for XBiotech Inc (XBIT), focusing on future EPS and revenue growth estimates. As of August 9, 2026, the company's stock is trading at 2.275 USD, with a market cap of 69.36M. The forecast section includes details on EPS, …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

XBiotech Inc (XBIT) Stock News Today

This article from TradingKey provides a news and analysis page for XBiotech Inc (XBIT) stock. It shows the current stock price, market cap, and links to various financial data and analytical tools. The page indicates that more news is expected soon.

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

XBiotech Inc (XBIT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for XBiotech Inc (XBIT), highlighting its current score of 2.62, which ranks 201 out of 384 in the Biotechnology & Medical Research industry. The company's beta of 0.81 indicates it tends to underperform in bull markets but experiences …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

XBiotech Inc (XBIT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of XBiotech Inc (XBIT), detailing its current price momentum score, support and resistance levels, and indicator readings. It also includes an overview of various technical indicators like MACD, RSI, and moving averages, offering insights into potential trading signals. …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

XBiotech Inc (XBIT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for XBiotech Inc (XBIT), noting its current valuation score of 7.74, ranking 184th in the Biotechnology & Medical Research industry. It highlights the company's current P/E ratio of -1.70, contrasting it with recent highs and lows. The analysis …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

XBIT|XBiotech Inc|Price:2.280|Chg%:+0.020

This article provides a comprehensive stock analysis of XBiotech Inc (XBIT) by TradingKey. It highlights the company's strong fundamentals and significant growth potential, although its stock price is expected to trend down in the medium term. The analysis also covers XBiotech's business in developing …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

XBiotech Inc (XBIT) Income Statement

This article provides the quarterly and annual income statements for XBiotech Inc (XBIT), detailing various financial metrics such as revenue, operating expenses, net income, and earnings per share. It also includes frequently asked questions about how to interpret these financial statements and key metrics …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

XBiotech Inc (XBIT) Institutional Confidence

XBiotech Inc (XBIT) has an institutional shareholding score of 3.00, placing it 192nd out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 12.25%, marking a 42.58% increase quarter-over-quarter. James Simons is the largest institutional shareholder with 0.07% …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Capital return Main company 🇺🇸 United States

XBiotech Inc (XBIT) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides dividend and stock split information for XBiotech Inc (XBIT). It indicates that XBiotech Inc has distributed a total of $0.00 in dividends over the past five years and currently has no dividend data available. The page also shows the current stock …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

XBiotech Inc (XBIT) Cash Flow

This article provides a comprehensive quarterly and annual cash flow statement for XBiotech Inc (XBIT), detailing operating, investing, and financing activities from FY2013Q4 to FY2026Q1. It includes specific figures for net income, operating gains/losses, changes in working capital, capital expenditures, and free cash flow. …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

XBiotech Inc (XBIT) Balance Sheet

This article presents the detailed balance sheet data for XBiotech Inc (XBIT) on a quarterly and annual basis, spanning several years. It includes key financial metrics such as cash and short-term investments, total assets, liabilities, and shareholders' equity, allowing investors to assess the company's …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

XBiotech Inc (XBIT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of XBiotech Inc (XBIT), listing its major individual shareholders and institutional holdings. It provides a breakdown of shareholder types by proportion and outlines institutional shareholding trends over several quarters. Additionally, it highlights activities of key shareholders and lists …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

XBiotech Inc (XBIT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for XBiotech Inc (XBIT). It notes that relevant data regarding business segments, regional revenue, and profit contribution has not been disclosed by the company yet, with 0.00% of revenue coming from the United States. The article …

XBIT main company
Sharemaestro market context Price below Trend Line 52 weeks -28.1% · Next-week setup negative 42.3% XBIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context